ArticleGynecology and minimally invasive therapy
Clinical Efficacy of Ultrasound-guided High-intensity Focused Ultrasound Ablation for Treating Breast Fibroadenoma of Different Sizes: A Retrospective Study.
Article in Gynecology and minimally invasive therapy. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Efficacy and safety of high-intensity focused ultrasound versus cryoablation for breast fibroadenomas: a systematic review and meta-analysis.Frontiers in oncology · 2026Pooled it
- Article
- Comparative Analysis of Clinical Efficacy of High-Intensity Focused Ultrasound Ablation and Radiofrequency Ablation in Patients with Benign Breast Tumors.Technology in cancer research & treatmentArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The aim of this study was to assess the clinical outcomes of ultrasound (US)-guided high-intensity focused ultrasound (HIFU) in patients with breast fibroadenoma (FA) of different sizes. Materials and Methods: A total of 88 patients with 245 lesions diagnosed with FA by core needle biopsy from January 2021 to November 2023 were included in this study. US-guided HIFU was performed under local anesthesia. Baseline and treatment characteristics were recorded and analyzed. FAs were divided into three groups according to the longest diameter for further analysis. After the treatment, follow-up with volume evaluation and physical examination was performed at 3, 6, and 12 months. Results: There were 56 FAs ≤10 mm (group 1), 144 FAs with a diameter of 10-20 mm (Group 2), and 45 FAs of 20-30 mm (Group 3). The sonication time of the three groups was 22.5 s, 45.0 s, and 83.0 s ( Conclusion: The current evidence indicated HIFU was effective and safe in treating breast FA of different sizes, and the VRR of FA >1 cm at 12 months post-HIFU was greater than that of FA <1 cm.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.